Imprese · 29/04/20021 min di lettura
Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 38 New Drug Applications
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is withdrawing approval of 38 new drug applications (NDAs). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.